ClinicalTrials.govpublic full text
Trial of ID-Specific Donor Vaccinated Lymphocyte Infusion for Patients With Myeloma Relapsing or Failing to Achieve a Complete Remission After an Allogenic Transplant
myeloma, multiple myeloma, vaccine, lymphocyte infusion, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 872560
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.